IL-22BP

interleukin-22 binding protein

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-22BP, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors. [Phase 1]